Smith Julie
Stoke Therapeutics, Inc. · Director
Smith Julie is listed in public filings as director. This Smith Julie insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Stoke Therapeutics, Inc. (STOK), and Exelixis Inc (EXEL). Investors use Smith Julie's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $887k20k shares | SellFeb 18, 2026 | $44.30 | -- | |
| $2.0M44.1k shares | SellFeb 18, 2026 | $44.50 | -- |